Plain-English translation of NCT04204915 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether people with severe aortic stenosis who don't yet have symptoms should have their valve replaced early, or whether they should be monitored closely instead. The trial will compare heart valve replacement surgery (or a minimally invasive procedure called TAVI) against a watching-and-waiting approach to see which strategy keeps people healthier and out of the hospital longer.
Doctors currently disagree about the best approach for people with severe aortic stenosis who feel fine—some recommend early surgery to prevent future problems, while others prefer to wait until symptoms appear. This trial aims to settle that question by finding out which approach actually leads to better health outcomes and prevents heart failure hospitalizations.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: either early valve replacement surgery (usually performed within 3 months) or careful monitoring with regular heart check-ups at your hospital. If you're in the surgery group, you'll have routine pre-surgery tests including possible coronary angiography (a special X-ray of your heart's blood vessels). You'll be followed over time to track whether you develop symptoms, need hospitalization, or experience other heart-related events.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Australia